McNeil H J, Miller M W, Conlon J A, Barker I K, Shewen P E
Department of Pathobiology, Ontario Veterinary College, University of Guelph, Canada.
J Wildl Dis. 2000 Jan;36(1):79-85. doi: 10.7589/0090-3558-36.1.79.
The safety and efficacy of a remotely delivered multivalent Pasteurella haemolytica supernatant vaccine (serotypes A2 and T10) were examined in captive Rocky, Mountain bighorn sheep (Ovis canadensis canadensis). Twenty bighorn sheep were grouped according to baseline leukotoxin neutralizing antibody titers (< or =2 or >2 log2(-1)) and vaccination history (previously vaccinated or unvaccinated). Within these groups, animals were randomly assigned to one of two delivery treatments: hand injection (control) or biobullet implantation. All bighorns received a single dose from the same lot of vaccine (n = 10/treatment); four additional animals were injected intramuscularly with 0.9% saline as unvaccinated sentinels. Mild, transient lameness one day after hand injection or biobullet implantation was the only adverse effect. Serum neutralizing antibody titers to P. haemolytica leukotoxin differed between delivery treatments (P = 0.009) and among baseline titer/vaccination history groups (P = 0.013). Neutralizing titers were higher among hand-injected bighorns. Although neutralizing titers were lower among implanted bighorns than hand-injected controls at 1 wk (P = 0.002) and 2 wk (P = 0.021) after vaccination, seroconversion rates in response to implantation (6/10) and hand injection (9/10) did not differ (P = 0.303). Agglutinating antibody titers to T10 were high and did not vary over time or between delivery treatments. Agglutinating antibody titers to A2 in the hand-injected controls were not different (P > or = 0.07) than those in bighorns vaccinated with biobullet implantation. These data demonstrate that although hand injection elicits higher absolute titers, biobullet implantation may also stimulate effective antibody responses to P. haemolytica supernatant vaccine. Further evaluation of biobullet vaccination against pneumonic pasteurellosis in free-ranging populations of wild bighorn sheep is warranted.
在圈养的落基山白大角羊(加拿大盘羊指名亚种)中检测了远程递送的多价溶血巴斯德菌上清液疫苗(血清型A2和T10)的安全性和有效性。根据基线白细胞毒素中和抗体滴度(≤2或>2 log2⁻¹)和疫苗接种史(先前接种过或未接种过)将20只白大角羊分组。在这些组中,动物被随机分配到两种递送处理之一:手工注射(对照)或生物子弹植入。所有白大角羊都接受了来自同一批次疫苗的单剂量(每组n = 10只);另外4只动物作为未接种疫苗的哨兵肌肉注射0.9%生理盐水。手工注射或生物子弹植入后一天出现的轻度、短暂跛行是唯一的不良反应。针对溶血巴斯德菌白细胞毒素的血清中和抗体滴度在递送处理之间(P = 0.009)以及在基线滴度/疫苗接种史组之间(P = 0.013)存在差异。手工注射的白大角羊的中和滴度更高。尽管在接种疫苗后1周(P = 0.002)和2周(P = 0.021),植入组白大角羊的中和滴度低于手工注射的对照组,但植入组(6/10)和手工注射组(9/10)的血清转化率没有差异(P = 0.